{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:18:05Z","timestamp":1791505085078,"version":"4.3.4"},"reference-count":59,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP180684"],"award-info":[{"award-number":["RP180684"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beyond Spring Pharmaceuticals"},{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Med"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.medj.2025.100752","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T10:46:00Z","timestamp":1751021160000},"page":"100752","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Plinabulin following radiation enhances dendritic cell maturation and checkpoint inhibitor retreatment of relapsed\/refractory cancers"],"prefix":"10.1016","volume":"6","author":[{"given":"Steven H.","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Subbiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Neri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan N.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjuan June","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye Lin","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gitanjali","family":"Jayachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrish","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penny","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Karp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Rodon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Kenneth","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Tonra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Reuben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqing","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medj.2025.100752_bib1","doi-asserted-by":"crossref","first-page":"S2492","DOI":"10.21037\/jtd.2018.05.73","article-title":"Combining immunotherapy with radiation therapy in thoracic oncology","volume":"10","author":"Badiyan","year":"2018","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.medj.2025.100752_bib2","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0140-6736(20)32598-8","article-title":"Enhancing anti-tumour efficacy with immunotherapy combinations","volume":"397","author":"Meric-Bernstam","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.medj.2025.100752_bib3","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.21037\/tlcr-22-140","article-title":"Safety and efficacy of retreatment with immune checkpoint inhibitors in non-small cell lung cancer: a systematic review and meta-analysis","volume":"11","author":"Cai","year":"2022","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.medj.2025.100752_bib4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ccell.2023.12.013","article-title":"Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer","volume":"42","author":"Memon","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.medj.2025.100752_bib5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.7150\/ijms.3635","article-title":"Cancer and radiation therapy: current advances and future directions","volume":"9","author":"Baskar","year":"2012","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.medj.2025.100752_bib6","first-page":"65","article-title":"Radiotherapy combination opportunities leveraging immunity for the next oncology practice","volume":"67","author":"Herrera","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.medj.2025.100752_bib7","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ijrobp.2020.08.023","article-title":"Radiation Therapy and the In Situ Vaccination Approach","volume":"108","author":"Golden","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.medj.2025.100752_bib8","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/s41591-018-0232-2","article-title":"Radiotherapy induces responses of lung cancer to CTLA-4 blockade","volume":"24","author":"Formenti","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.medj.2025.100752_bib9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S2213-2600(20)30391-X","article-title":"Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials","volume":"9","author":"Theelen","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.medj.2025.100752_bib10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1200\/JCO.20.00290","article-title":"Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma","volume":"39","author":"McBride","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.medj.2025.100752_bib11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1470-2045(21)00658-6","article-title":"Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial","volume":"23","author":"Schoenfeld","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.medj.2025.100752_bib12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijrobp.2020.06.007","article-title":"High-Dimensional Characterization of the Systemic Immune Landscape Informs on Synergism Between Radiation Therapy and Immune Checkpoint Blockade","volume":"108","author":"Chua","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.medj.2025.100752_bib13","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41423-023-00990-6","article-title":"Dendritic cell subsets in cancer immunity and tumor antigen sensing","volume":"20","author":"Del Prete","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.medj.2025.100752_bib14","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.immuni.2014.04.016","article-title":"Development and function of dendritic cell subsets","volume":"40","author":"Mildner","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.medj.2025.100752_bib15","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.immuni.2023.09.011","article-title":"The cancer-immunity cycle: Indication, genotype, and immunotype","volume":"56","author":"Mellman","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.medj.2025.100752_bib16","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1158\/0008-5472.CAN-13-1342","article-title":"Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells","volume":"74","author":"Goc","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.medj.2025.100752_bib17","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1016\/j.celrep.2019.08.057","article-title":"GEF-H1 Signaling upon Microtubule Destabilization Is Required for Dendritic Cell Activation and Specific Anti-tumor Responses","volume":"28","author":"Kashyap","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.medj.2025.100752_bib18","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1016\/j.chempr.2019.08.022","article-title":"Structure, Thermodynamics, and Kinetics of Plinabulin Binding to Two Tubulin Isotypes","volume":"5","author":"La Sala","year":"2019","journal-title":"Chem"},{"key":"10.1016\/j.medj.2025.100752_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.644608","article-title":"Plinabulin, a Distinct Microtubule-Targeting Chemotherapy, Promotes M1-Like Macrophage Polarization and Anti-tumor Immunity","volume":"11","author":"Natoli","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.medj.2025.100752_bib20","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S2213-2600(24)00178-4","article-title":"Plinabulin plus docetaxel versus docetaxel in patients with non-small-cell lung cancer after disease progression on platinum-based regimen (DUBLIN-3): a phase 3, international, multicentre, single-blind, parallel group, randomised controlled trial","volume":"12","author":"Han","year":"2024","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.medj.2025.100752_bib21","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.ijrobp.2014.05.203","article-title":"Radiation Therapy Sensitizes a Poorly Immunogenic Breast Cancer to PD-1 Blockade","volume":"90","author":"Pilones","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.medj.2025.100752_bib22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/bs.ircmb.2023.02.002","article-title":"The role of dendritic cells in radiation-induced immune responses","volume":"378","author":"Preet Kaur","year":"2023","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.medj.2025.100752_bib23","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.4049\/jimmunol.2000194","article-title":"Dendritic Cell Maturation Defines Immunological Responsiveness of Tumors to Radiation Therapy","volume":"204","author":"Blair","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.medj.2025.100752_bib24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.medj.2025.100752_bib25","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.1158\/1078-0432.CCR-09-0265","article-title":"Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody","volume":"15","author":"Dewan","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.medj.2025.100752_bib26","doi-asserted-by":"crossref","first-page":"8340","DOI":"10.3390\/ijms22158340","article-title":"Dendritic Cells and CCR7 Expression: An Important Factor for Autoimmune Diseases, Chronic Inflammation, and Cancer","volume":"22","author":"Brandum","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.medj.2025.100752_bib27","first-page":"176","article-title":"Single-cell profiling of the developing mouse brain and spinal cord with split-pool barcoding","volume":"360","author":"Rosenberg","year":"2018","journal-title":"Sci. Technol. Humanit."},{"key":"10.1016\/j.medj.2025.100752_bib28","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41587-021-01033-z","article-title":"Differential abundance testing on single-cell data using k-nearest neighbor graphs","volume":"40","author":"Dann","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.medj.2025.100752_bib29","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2018.11.043","article-title":"Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma","volume":"176","author":"Li","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.medj.2025.100752_bib30","article-title":"Microtubules restrict F-actin polymerization to the immune synapse via GEF-H1 to maintain polarity in lymphocytes","author":"Pineau","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.medj.2025.100752_bib31","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.ccell.2021.10.009","article-title":"Single-cell analysis of human non-small cell lung cancer lesions refines tumor classification and patient stratification","volume":"39","author":"Leader","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.medj.2025.100752_bib32","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005755","volume":"10","author":"Chesney","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.medj.2025.100752_bib33","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.medj.2025.100752_bib34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc3258","article-title":"Cancer immunotherapy via dendritic cells","volume":"12","author":"Palucka","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.medj.2025.100752_bib35","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200264","article-title":"Tumor-infiltrating dendritic cell states are conserved across solid human cancers","volume":"218","author":"Gerhard","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.medj.2025.100752_bib36","doi-asserted-by":"crossref","first-page":"437","DOI":"10.32604\/or.2023.029924","article-title":"Tumor neoantigens: Novel strategies for application of cancer immunotherapy","volume":"31","author":"Guan","year":"2023","journal-title":"Oncol. Res."},{"key":"10.1016\/j.medj.2025.100752_bib37","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1182\/bloodadvances.2023011533","article-title":"Patterns of progression after immune checkpoint inhibitors for Hodgkin lymphoma: implications for radiation therapy","volume":"8","author":"Burlile","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.medj.2025.100752_bib38","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.78330","article-title":"Microtubules restrict F-actin polymerization to the immune synapse via GEF-H1 to maintain polarity in lymphocytes","volume":"11","author":"Pineau","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.medj.2025.100752_bib39","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/s41586-024-08257-4","article-title":"Cancer cells impair monocyte-mediated T cell stimulation to evade immunity","volume":"637","author":"Elewaut","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.medj.2025.100752_bib40","first-page":"A1720","article-title":"1491 Phase 2 study of pembrolizumab (pemb) plus plinabulin (plin) and docetaxel (doc) for NSCLC patients (pts) after failure on immune checkpoint inhibitor therapy: initial efficacy and safety results","volume":"12","author":"Xu","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.medj.2025.100752_bib41","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/cncr.34565","article-title":"A phase 2 trial of chemotherapy plus pembrolizumab in patients with advanced non-small cell lung cancer previously treated with a PD-1 or PD-L1 inhibitor: Big Ten Cancer Research Consortium BTCRC-LUN15-029","volume":"129","author":"Salous","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.medj.2025.100752_bib42","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7150\/jca.2.81","article-title":"Phase I Dose Escalation Study of Sodium Stibogluconate (SSG), a Protein Tyrosine Phosphatase Inhibitor, Combined with Interferon Alpha for Patients with Solid Tumors","volume":"2","author":"Naing","year":"2011","journal-title":"J. Cancer"},{"key":"10.1016\/j.medj.2025.100752_bib43","doi-asserted-by":"crossref","first-page":"35656","DOI":"10.18632\/oncotarget.10290","article-title":"Circulating tumor cells (CTCs) are associated with abnormalities in peripheral blood dendritic cells in patients with inflammatory breast cancer","volume":"8","author":"Mego","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.medj.2025.100752_bib44","doi-asserted-by":"crossref","first-page":"D933","DOI":"10.1093\/nar\/gkac958","article-title":"Ensembl 2023","volume":"51","author":"Martin","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.medj.2025.100752_bib45","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nbt.3192","article-title":"Spatial reconstruction of single-cell gene expression data","volume":"33","author":"Satija","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.medj.2025.100752_bib46","unstructured":"Hafemeister, C., and Satija, R. (2021). Analyzing scRNA-Seq Data with the Sctransform and Offset Models."},{"key":"10.1016\/j.medj.2025.100752_bib47","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.medj.2025.100752_bib48","doi-asserted-by":"crossref","first-page":"47","DOI":"10.12688\/f1000research.22139.1","article-title":"scRepertoire: An R-based toolkit for single-cell immune receptor analysis","volume":"9","author":"Borcherding","year":"2020","journal-title":"F1000Res."},{"key":"10.1016\/j.medj.2025.100752_bib49","doi-asserted-by":"crossref","first-page":"D942","DOI":"10.1093\/nar\/gkac1071","article-title":"GENCODE: reference annotation for the human and mouse genomes in 2023","volume":"51","author":"Frankish","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.medj.2025.100752_bib50","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","article-title":"DoubletFinder: Doublet Detection in Single-Cell RNA Sequencing Data Using Artificial Nearest Neighbors","volume":"8","author":"McGinnis","year":"2019","journal-title":"Cell Syst."},{"key":"10.1016\/j.medj.2025.100752_bib51","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/s41593-021-00913-6","article-title":"A human forebrain organoid model of fragile X syndrome exhibits altered neurogenesis and highlights new treatment strategies","volume":"24","author":"Kang","year":"2021","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.medj.2025.100752_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.margen.2019.100723","article-title":"t-Distributed Stochastic Neighbor Embedding (t-SNE): A tool for eco-physiological transcriptomic analysis","volume":"51","author":"Cieslak","year":"2020","journal-title":"Mar. Genom."},{"key":"10.1016\/j.medj.2025.100752_bib53","article-title":"Umap: Uniform manifold approximation and projection for dimension reduction","author":"McInnes","year":"2020","journal-title":"arXiv"},{"key":"10.1016\/j.medj.2025.100752_bib54","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","article-title":"Comprehensive Integration of Single-Cell Data","volume":"177","author":"Stuart","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.medj.2025.100752_bib55","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.medj.2025.100752_bib56","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.patcog.2010.12.015","article-title":"Supervised principal component analysis: Visualization, classification and regression on subspaces and submanifolds","volume":"44","author":"Barshan","year":"2011","journal-title":"Pattern Recogn."},{"key":"10.1016\/j.medj.2025.100752_bib57","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1126\/science.1254257","article-title":"Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma","volume":"344","author":"Patel","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.medj.2025.100752_bib58","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s13059-019-1862-5","article-title":"scPred: accurate supervised method for cell-type classification from single-cell RNA-seq data","volume":"20","author":"Alquicira-Hernandez","year":"2019","journal-title":"Genome Biol."},{"key":"10.1016\/j.medj.2025.100752_bib59","doi-asserted-by":"crossref","first-page":"bbab567","DOI":"10.1093\/bib\/bbab567","article-title":"A comprehensive comparison of supervised and unsupervised methods for cell type identification in single-cell RNA-seq","volume":"23","author":"Sun","year":"2022","journal-title":"Brief. Bioinform."}],"container-title":["Med"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634025001795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634025001795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T22:01:10Z","timestamp":1762639270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666634025001795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":59,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2666634025001795"],"URL":"https:\/\/doi.org\/10.1016\/j.medj.2025.100752","relation":{},"ISSN":["2666-6340"],"issn-type":[{"value":"2666-6340","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plinabulin following radiation enhances dendritic cell maturation and checkpoint inhibitor retreatment of relapsed\/refractory cancers","name":"articletitle","label":"Article Title"},{"value":"Med","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medj.2025.100752","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100752"}}